New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Saturday, Nov 21, 2026
Export PASG’s income statement to Excel — free account
Passage Bio, Inc.
PASG- EPS
- n/m
- Free cash flow
- n/m
Quarter to September 2026, against a year earlier
3.92
0.31
+8.59%
Follow PASG
Alert me
What it owns vs. what it owes End of fiscal 2025, Dec 31, 2025
Shareholders’ equity is 30.1% of the balance sheet. What is a balance sheet?
Owns
$14.5MLong-term assets
$1.5MOther short-term assets
$46.3MCash & short-term investments
Funded by
$18.8MShareholders’ equity
$43.5MOther liabilities
Debt is 0.00% of the total; shareholders’ equity 30.1%.
| Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
24.86 | 158.87 | 304.82 | 315.77 | 189.61 | 114.29 | 76.76 | 46.30 |
Other current assets |
8.54 | 6.75 | 10.96 | 7.57 | 6.51 | 2.74 | 1.22 | 0.83 |
Total current assets |
33.40 | 165.78 | 317.18 | 325.07 | 197.04 | 117.96 | 78.82 | 47.76 |
Property, Plant, Equpment (Net) |
0.03 | 1.09 | 2.80 | 23.81 | 22.52 | 15.30 | 9.33 | 4.11 |
Long-term assets (Other) |
0.03 | 11.75 | 8.03 | 6.20 | 4.27 | 0.43 | 0.46 | 0.24 |
Total non-current assets |
— | 12.84 | 10.82 | 30.01 | 46.51 | 32.59 | 23.60 | 14.52 |
Total Assets |
33.46 | 178.61 | 328.01 | 355.08 | 243.55 | 150.55 | 102.41 | 62.28 |
Accounts Payable |
0.21 | 0.63 | 5.27 | 9.45 | 4.07 | 1.30 | 0.74 | 1.11 |
Accrued Expenses |
— | 3.05 | 15.91 | 20.05 | 11.01 | 11.67 | 6.71 | 4.65 |
Other current liabilities |
0.10 | 3.05 | 15.91 | 20.05 | 11.01 | — | 8.23 | 13.75 |
Total current liabilities |
0.31 | 3.68 | 21.18 | 29.50 | 18.35 | 16.34 | 19.36 | 23.08 |
Non-current Revenue (Deferred) |
— | 0.50 | 2.08 | 6.92 | — | — | — | — |
Liabilities (Preferred Stock) |
— | 230.61 | — | — | — | — | — | — |
Non-current Liabilities (Other) |
2.21 | 0.08 | 0.04 | — | — | — | — | — |
Total non-current liabilities |
— | 231.19 | 2.12 | 6.92 | 23.83 | 22.92 | 21.79 | 20.44 |
Total liabilities |
2.52 | 234.87 | 23.29 | 36.42 | 42.18 | 39.26 | 41.15 | 43.53 |
Additional Paid In Capital |
— | 2.41 | 475.62 | 675.35 | 694.73 | 705.79 | 720.49 | 723.51 |
Common Stock (Net) |
0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | — |
Retained Earnings |
(13.03) | (58.66) | (170.89) | (356.28) | (492.41) | (594.47) | (659.23) | (704.76) |
Common Equity (Total) |
(12.17) | (56.25) | 304.71 | 318.66 | 201.37 | 111.28 | 61.26 | 18.76 |
Shareholders Equity (Total) |
(12.17) | (56.25) | 304.71 | 318.66 | 201.37 | 111.28 | 61.26 | 18.76 |
Shareholders Equity and Liabilities (Total) |
— | 178.61 | 328.01 | 355.08 | 243.55 | 150.55 | 102.41 | 62.28 |
Shares (Common) |
— | 0.21 | 2.28 | 2.71 | 2.73 | 2.75 | 3.16 | 3.18 |
Shareholders Equity (Tangible) |
— | (56.25) | 304.71 | 318.66 | 201.37 | 111.28 | 61.26 | 18.76 |
Net Debt |
(24.86) | (158.87) | (304.82) | (315.77) | (189.61) | (114.29) | (76.76) | (46.30) |
Total Debt |
— | — | — | — | 27.11 | — | — | — |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 12, 2026